Authors:
SNEL S
JANSEN JA
PEDERSEN PC
JONKMAN JHG
VANHEININGEN PNM
Citation: S. Snel et al., TIAGABINE, A NOVEL ANTIEPILEPTIC AGENT - LACK OF PHARMACOKINETIC INTERACTION WITH DIGOXIN, European Journal of Clinical Pharmacology, 54(4), 1998, pp. 355-357
Authors:
SNEL S
JANSEN JA
MENGEL HB
RICHENS A
LARSEN S
Citation: S. Snel et al., THE PHARMACOKINETICS OF TIAGABINE IN HEALTHY ELDERLY VOLUNTEERS AND ELDERLY PATIENTS WITH EPILEPSY, Journal of clinical pharmacology, 37(11), 1997, pp. 1015-1020
Authors:
SKRUMSAGER BK
CHRISTENSEN JV
SNEL S
SEIBERLING M
Citation: Bk. Skrumsager et al., TOLERABILITY, SAFETY AND PHARMACOKINETICS OF SINGLE-DOSE AND MULTIPLEDOSING OF THE SELECTIVE D1 ANTAGONIST NNC-01-0687 IN HEALTHY-SUBJECTS, Psychopharmacology, 121(3), 1995, pp. 294-299
Authors:
MENGEL H
JANSEN JA
SOMMERVILLE K
JONKMAN JHG
WESNES K
COHEN A
CARLSON GF
MARSHALL R
SNEL S
DIRACH J
KASTBERG H
Citation: H. Mengel et al., TIAGABINE - EVALUATION OF THE RISK OF INTERACTION WITH THEOPHYLLINE, WARFARIN, DIGOXIN, CIMETIDINE ORAL-CONTRACEPTIVES, TRIAZOLAM, OR ETHANOL, Epilepsia, 36, 1995, pp. 160-160
Citation: Sh. Ingwersen et al., NONLINEAR MULTIPLE-DOSE PHARMACOKINETICS OF THE DOPAMINE REUPTAKE INHIBITOR VANOXERINE, Journal of pharmaceutical sciences, 82(11), 1993, pp. 1164-1166